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Abstract 
 
Blood glucose monitors are critical to diabetes management.  Many new non-
invasive measurement techniques are being investigated. The present work focuses on the 
possibility of a monitor that non-invasively measures blood glucose levels using 
electromagnetic waves.  The technique is based on relating a monitoring antenna’s 
resonant frequency to the permittivity and conductivity of blood which in turn is related 
to the glucose levels.  
At first a realistic data base for the dielectric properties of blood has been 
established through in-vitro measurements performed on blood samples obtained from 20 
patients with glucose levels ranging from normal (87 mg/dl) to hyperglycemic (330 
mg/dl). Using the Agilent 85070E dielectric probe and an Agilent 8720B network 
analyzer the dielectric permittivity and conductivity of the blood samples have been 
measured over a frequency range of 1GHz – 10GHz. The Cole-Cole model has been 
modified through curve fitting to in-vitro data that includes a factor representing glucose 
levels.  
Two antennas (wideband and narrowband) have been designed, constructed and 
tested in free space.  A simulation model of layered tissue and blood together with an 
antenna has been created to study the effect of changing glucose levels. It is noted that 
the antenna’s resonant frequency increases with increase in glucose levels.    
An analytical model for the antenna has been developed, which has been 
validated with simulations. The model consists of a lumped-element antenna that 
represents a narrowband radiator. The resonant frequency of the radiator is dictated by a 
resonant LCR circuit, which is a function of the materials within the antenna’s near-field. 
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A measurement system has been developed to measure the resonant frequency of 
the antenna. A frequency synthesizer generates an RF signal over the desired frequency 
range. This signal is sent to the antenna through a directional coupler that generates 
forward and reflected signals. These voltages are measured and the reflection coefficient 
is calculated with a microprocessor. 
As an experimental verification, two antennas were strapped one on each leg of a 
patient with one antenna connected to the PNA and the other to the measurement system. 
As the patient ingested fast acting glucose tablets, the blood glucose level was measured 
by a traditional glucose meter. At the same time, a comparison of the resonant frequency 
of the antenna measured by the PNA and by the measurement system showed good 
agreement.    Further, it is seen that the antenna resonant frequency increases as the 
glucose level increases, which is consistent with the simulation model.    
vi 
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 1. Introduction and 
1.1 Diabetes Mellitus
 
Diabetes mellitus, oft
which a person has high blood sugar. This high blood sugar will often cause symptoms of 
frequent urination, increased hunger and increased thirst. The two types that affect the 
general population are known as Type 1 and Ty
Type 1 diabetes (often known as juvenile diabetes) is a condition in which 
pancreatic β-cell destruction usually leads to absolute insulin deficiency. This results in 
the inability to maintain glucose homoeostasis. Susceptibility to Type 1 
largely inherited, but there are also environmental triggers that are not fully understood. 
Of those with Type 1 diabetes, 50
Figure 1: Typical blood glucose control 
 
 
 
Background 
 
en referred to as diabetes is a group of metabolic diseases in 
pe 2 diabetes.  
diabetes is 
-60% of patients are under 18 years of age 
system. [27] 
1 
[1]. 
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Type 2 diabetes is characterized by a resistance to insulin, and in some cases 
absolute insulin deficiency. Lifestyles are significant factors in acquiring Type 2 diabetes. 
In one study, those that had high levels of physical activity, a healthy diet, did not smoke, 
consumed alcohol in moderation and were a healthy weight had a 89% lower diabetes 
Type 2 rate [2].  
 Diabetes can result in chronic conditions such as Vascular Disease, Renal 
Complications, and a variety of neurological symptoms. In 2003, the cost of treating 
diabetes was estimated to be $132 billion. By 2020 it is estimated the number of people 
diagnosed with diabetes could rise to over 17 million, costing an estimated $192 billion  
[3]. 
 While there is no cure for diabetes, symptoms are controlled through the 
regulation of blood glucose levels. There are several types of measurements that can be 
used to monitor glucose regulation. Once in the blood stream, glucose combines with 
hemoglobin found in red blood cells (erythrocytes) to create glycated hemoglobin 
(HBA1C). The hemoglobin will remain glycated for the life of the erythrocyte, typically 
90-120 days [4]. This makes HbA1c concentration measurement the best indication of 
average blood glucose concentration. While HbA1c measurements are the best method of 
long-term control, self monitoring of blood glucose levels is fundamental to diabetes 
care. Frequent monitoring avoids hypoglycemia, and aids in determining dietary choices, 
physical activity, and insulin doses. 
Most at-home monitoring is performed with a blood glucose monitor. While 
current blood glucose monitors require small amounts of blood (2-10 µL) and can be used 
at sites other than the fingertips, it is still a painful and tedious measurement. Although 
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blood glucose measurements fluctuate much more than HbA1c measurements, there is a 
strong correlation between HbA1c measurements and average glucose measurements 
taken over the same time period [5]. Continuous monitoring systems also exist, but they 
require a subcutaneous injection to be replaced every 3 to 7 days. While it has been 
shown that continuous monitoring systems are effective in reducing blood glucose to 
recommended levels [6], adolescents and young adults often have difficulty adhering to 
this intensive treatment. For this reason non-invasive monitoring systems would be 
preferred.  
1.2 Invasive Glucose Monitoring Techniques 
 
Current glucose monitoring devices are extremely similar to the devices originally 
created in the 1960’s. [7] Aside from the miniaturization, ease of use and the ability to 
log data, the measurements fundamentally are the same as the first laboratory sensors. A 
blood sample is placed in contact with an enzyme (typically glucose oxidase) which 
produces hydrogen peroxide from glucose and oxygen. The hydrogen peroxide quantity 
is then measured amperometrically with a (typically platinum) electrode. The vast 
majority of monitoring systems sold today, whether continuous or blood meters, use 
enzyme-coated electrodes and amperometric analysis.  
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There are several downsides to the current offerings of glucose meters. The blood 
meters require a blood sample, which is a painful procedure. If repeatedly measured, 
thick calluses can form on the fingertips causing more pain over time to draw blood. 
Continuous glucose monitoring systems (CGMS) provide the ability to continuously 
monitor glucose levels, but they require additional calibration to blood samples, as they 
often measure interstitial fluid. Perhaps the greatest downside, however, is the cost of 
current monitors. CGMS can cost several thousand dollars, and while blood monitors are 
relatively inexpensive, the electrodes are disposable and become costly over time. A 
single-use blood electrode strip costs about $1, and a CGMS 3-7 day sensor can cost $30-
$50. For people who measure their blood glucose level several times a day, the 
measurement strips can become a significant expenditure. 
Figure 2: Simplified glucose measurement method. [8] 
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Clearly, a reusable, non-invasive glucose monitoring system would be beneficial. 
This has been a heavily researched field in recent years. Various non-invasive glucose 
monitoring techniques will be discussed in the next section. 
1.3 Non-Invasive Glucose Monitoring Techniques 
 
 
Non-invasive glucose monitoring techniques have been heavily researched over 
the past several decades. The current areas of research will now be discussed. They have 
been divided into the following categories: Interstitial fluid chemical analysis, Breath 
chemical analysis, Infrared spectroscopy, Optical coherence tomography, Temperature-
modulated localized reflectance, Raman spectroscopy, Polarity changes, Ultrasound, 
Fluorescence, Thermal spectroscopy, Ocular spectroscopy, and Impedance spectroscopy. 
1.3.1 Interstitial Fluid Chemical Analysis 
 
Of all non-invasive monitoring techniques, Interstitial fluid (ISF) chemical 
analysis is the most like traditional invasive monitors. There is an enzymatic reaction 
Figure 3: Lifescan OneTouch Ultra glucose meter[9] (left), and Medtronics CGMS [10](right). 
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very similar to the one already described, except that the reaction is performed on ISF 
that is excreted through the skin. The most significant ISF glucose monitor was called 
Glucowatch®, designed by Cygnus inc[11]. The monitor was in a watch form factor, 
with a disposable pad pressed against the skin to absorb the ISF. The Glucowatch® has 
been shown able to effectively measure blood glucose levels in several clinical trials 
[12],[13], and was approved by the FDA in 2001. The company that manufactured it, 
however, has been shut down in 2005. It has been suggested that this was caused by a 
combination of technical issues and high costs to the user (in addition to a $700 meter, 
the cost of the disposable pads was greater than $5000 per year)[14]. It is unknown if 
similar techniques are currently being used on new products. 
1.3.2 Breath Chemical Analysis 
 
Another chemical analysis technique involves the measurement of acetone in an 
exhaled breath. It has been shown that the level of acetone in exhaled breaths sharply 
rises in diabetic patients, and increases as a function of blood glucose levels. A system 
has been designed which can chemically analyze exhaled air, which can be used to 
determine blood glucose levels [15]. 
1.3.3 Infrared Spectroscopy 
 
Infrared spectroscopy can be separated into two categories, Near-infrared 
spectroscopy (NIR) and Mid-Infrared spectroscopy (Mid-IR). NIR is a lower frequency 
measurement in which the transmission and reflection of infrared light is used to 
characterize blood glucose levels [16]. Some designs provide a depth resolution through 
the use of a confocal system [17]. It is typically performed in an area of the body with 
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relatively thin tissue like an earlobe, upper lip, or finger web. Due to the frequency of the 
light, this measurement is sensitive to changes in skin structure than can found in subjects 
with chronic hyperglycemia. A recent investigation has also been performed into the 
possibility of an NIR optical implant [18]. Mid-IR uses essentially the same technique as 
NIR, although there is typically not enough light penetration at Mid-IR frequencies for 
transmission analysis to be performed. As a result, only reflection analysis is used. 
Infrared spectroscopy has not yet been shown to be a reliable measurement technique. 
1.3.4 Optical Coherence Tomography 
 
Optical coherence tomography (OCT) is a specific form of light scattering 
measurement in which the phase component of reflected light is measured. OCT utilizes a 
low coherence (wide frequency spectrum) light source, which is sent from an 
interferometer to a reference mirror and to the subject (typically an arm)[19]. The 
reflected light from both the subject and the mirror are then correlated. By moving the 
subject location and the reference mirror location, an image can be generated with both 
lateral and in-depth scanning. An increase in ISF glucose levels causes an increase in 
refractive index, which can be seen in the generated images. 
1.3.5 Temperature-modulated localized reference 
 
Temperature-modulated localized reflectance is another form of light scattering 
measurement. Tissue have varying refractive index based on temperature, but the 
variation is also a factor of glucose concentrations [20]. By modulating skin temperature 
between 22 and 38 degrees C, variations in light packets reflected can be used to 
determine glucose levels. 
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1.3.6 Raman Spectroscopy 
 
Raman spectroscopy is a method in which an oscillation is generated in a fluid 
which causes changes in light scattering properties [21]. Specifically, this technique can 
be used to measure glucose concentrations in the front of the eye. A laser is used to 
stimulate glucose molecules to oscillate in the ocular fluid. The scattered light from the 
oscillation is an indicator of the glucose concentration. A negative to this technique is the 
potential interference from other molecules. 
1.3.7 Polarization Change 
 
Another optical technique being investigated in the eye is that of polarization 
change. The polarization of a polarized light source will change angle slightly if it is 
passed through a solution of chiral molecules, such as glucose [22]. While this technique 
is feasible, pH and interfering compounds have prevented high specificity. 
1.3.8 Ultrasound 
 
A promising technique for monitoring glucose levels exists that utilizes 
ultrasound. Several types have been investigated, but they all essentially operate on the 
same principles. A short laser burst is used to locally heat a small tissue area, which 
causes an ultrasonic pulse to propagate through the tissue. The photoacoustic excitation is 
dependent on the laser frequency. As the laser frequency is varied, the concentration of 
glucose levels in fluids can be determined from the photoacoustic spectrum [23].  
1.3.9 Fluorescence 
 
A study has demonstrated that fluorescence can be used as an indicator of glucose 
concentrations [16]. By exciting tissue with an ultraviolet laser, the tissue generates 
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fluorescence at 380 nm, the intensity of which is dependent on glucose levels. This has 
limited capabilities since the intensity is strongly affected by skin pigment and thickness. 
1.3.10 Thermal Spectroscopy 
 
Thermal spectroscopy is the measurement of infrared radiation emitting from the 
human body. While other factors are significant as well, glucose concentration has been 
shown to have an absorptive effect on the quantity of human body infrared emission [11]. 
1.3.11 Ocular Spectroscopy 
 
Ocular spectroscopy is a method through which tears are chemically analyzed to 
reveal glucose levels. A contact lens has been designed [24], which reacts with the 
glucose in tears. When emitted with a light source, such as a laser, the reflected light 
changes wavelength based upon the glucose concentration, which can be measured with a 
spectrometer. 
1.3.12 Impedance Spectroscopy 
 
Impedance spectroscopy is the study of interaction between electromagnetic 
radiation and matter as a function of wavelength (λ). While other blood glucose 
measurement techniques utilize infrared or visible light spectroscopy, this technique 
focuses on the use of radio frequency radiation. This involves the measurement of the 
impedance of human tissues in the radio frequency range, which will ultimately be used 
to characterize blood glucose levels. While this describes the present work, there have 
been other research groups that have investigated the possibility of a radio frequency 
impedance spectroscopy system for blood glucose monitoring. They will be discussed at 
greater length. The following research is supportive and encouraging to the present work, 
10 
 
but there are clear areas that were not investigated fully that are addressed later in this 
paper. 
There have been two research groups that have previously published work in this 
field. The first group began publishing their work in 2000 [25]. It involved a novel sensor 
based on a resonant RLC circuit [26]. 
 
 
 
The resonant frequency of the sensor was detected by measuring the impedance 
magnitude of the resonant circuit through a voltage divider. The frequency was swept 
through the desired frequency range by the configuration of a digital to analog converter 
(DAC).  
Figure 4: Simple electrical model of skin sensor used by Pendragon device. [26] 
11 
 
 
 
 
Immediately, there are several potential issues that can be identified with this 
device. Since the resonant circuit is placed directly on the skin, the quality factor (Q) of 
the capacitor is a function of the dielectric losses of the skin. In addition, the 
measurement method only measures the magnitude of the resonant frequency impedance. 
This means that for a very low Q, without detecting any phase component it could be 
very difficult to identify the true resonant frequency. Finally, despite the temperature 
compensation that is performed digitally, controlling the VCO with a DAC outside of a 
phase-locked-loop (PLL) significantly reduces the frequency accuracy. If a PLL was used 
to control the loop, the temperature variation of a VCO could be compensated for while 
introducing only minor frequency inaccuracy from a crystal resonator. 
Figure 5: Block diagram of Pendragon blood glucose sensing system. [26] 
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Despite these possible issues with the design, there were some promising 
experiments performed and published (Figure 6). 
 
 
 
The device was productized into a watch form factor called Pendra® by 
Pendragon Medical and approved by the CE regulatory body in 2003. The calibration 
procedure required a 2-3 day process, after which approximately 30% of the users had to 
give up wearing the sensors. This was due to skin conditions, impedance, or other factors 
that the Pendra® system was unable to account for. After an initial launch in 2004 to 
several European markets, significant technical problems caused the Pendragon Medical 
to file for bankruptcy.  
A detailed analysis of data from the Pendra® system has shown that its 
correlation to actual glucose values was only 35.1% and that it provided potentially 
dangerous readings to its users. The Clarke error grid can be shown in Figure 7, in which 
Figure 6: Experimental data of Pendragon blood glucose monitoring system, showing sensor signal, blood 
glucose concentration (measured invasively) and interstitial fluid glucose concentration. [26] 
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a significant amount of the readings fall into the dangerous D and E zones. 
 
 
 
Another promising radio frequency impedance spectroscopy system has been 
developed by Buford Randall Jean and Eric C, Green at Baylor University [27]. Rather 
than an open-ended resonant circuit, the team at Baylor University has opted to use a 
resonant-spiral transmission line (Figure 8).  
 
Figure 7: Clarke error grid from a study of the Pendragon blood glucose monitor. [25] 
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For various blood glucose levels, the sensor has been shown to resonate at 
different frequencies. This response shows many maximums and minimums which are 
used for analysis. Like previous work, the phase component has not been used for 
analysis.  
 
 
 
Figure 9: Frequency change in S21 response of device developed by Baylor University. [27] 
Figure 8: Resonant spiral transmission line developed by Baylor University research team, and S21 
measurements during “soda” test. [27] 
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This research group has also provided similar promising results that show a 
significant response to glucose consumption, shown in Figure 9, from their “soda test”, 
but has not shown the correlation of this data to glucose levels. 
 
  
 
The form factor of this device is shown in Figure 10. The spiral is a pad on which 
a thumb is pressed [28]. Clearly, like previous work, the physical orientation of the 
subject with regard to the device is critical to the measurement. 
While both of these research groups have shown promising experimental 
evidence, neither has provided any insight on the mechanism that causes their devices to 
work. Both of their devices make us of only magnitude and not phase data. Both of these 
discrepancies will be addressed in future chapters, in addition to other work. 
There is another group currently working on antennas for continuous blood 
glucose monitoring [44]. While this research group has focused on the use of an 
implanted antenna for data communication, there has been significant progress in the 
design of an antenna for use in direct contact with human tissues. A serpentine antenna 
Figure 10: Resonant spiral glucose measurement device without (left) and with thumb guide (right). [28] 
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has been designed (Figure 11) that has been designed to operate in the presence of 
tissues. 
 
 
Gels that mimic the dielectric properties of skin have been created, and it can be 
seen (Figure 12) that the antenna’s response changes whether or not it is in the presence 
of the skin gel. 
 
 
Figure 11: Serpentine antenna (left) embedded in human tissue (right) [44]. 
Figure 12: Serpentine antenna in air and in mimicking gel [44]. 
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In the present work, an antenna will be designed to provide the same effect. For 
our purposes, the resonant frequency of the antenna will be used as a measurement 
method, not for communication. 
1.4 Dielectric Properties of Blood 
 
In order to better understand the mechanism for a radio frequency glucose 
monitoring system to work, we must explore the properties that affect electromagnetic 
devices. Every medium, including biological materials can be described by a frequency-
dependant complex relative permittivity [29].  
   ′  "      (1) 
The real part of the permittivity ε’ denotes the amount of electromagnetic energy 
stored in a material relative to that stored in a vacuum.  
The imaginary part of the permittivity jε” is a loss factor describing the dielectric 
losses in the material. It can be re-written as equation 2 [30], 
"          (2) 
where σ is the total conductivity of the material, which may include a contribution from a 
frequency-independent ionic conductivity. ε0 is the permittivity of free space, and ω is the 
angular frequency of the field. 
The dielectric properties are often determined as ε’ and σ values, which is how 
they will be referenced for the rest of this work. 
The dielectric properties of blood, like all tissues, are not constant over frequency. 
They vary based on frequency, called dispersion. There are many dispersion zones, 
frequency ranges in which certain mechanisms (macromolecules, water molecules, etc.) 
will dominate the dielectric properties of the medium [30]. Each of these zones can be 
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modeled with separate term of a Debye or Cole-Cole Model. Both of these models have 
multiple terms that can be used to describe the dielectric properties of a medium 
accurately. These models have already been used extensively by research groups to 
characterize blood, as well as other human tissues. They will be discussed later in greater 
detail. 
There has already been extensive characterization of blood dielectric properties 
[31].  In 1996, a research group from King’s College published a thorough series of 
papers in which blood and 16 other types of human tissue were measured with an 
impedance analyzer and modeled [32]. This information has been modeled and compiled 
into a database which has served as a reference for human tissue dielectric properties.  
While human tissue dielectric properties have been characterized, there is little 
information present regarding the effect of blood glucose levels on blood dielectric 
properties in the radio frequency range. What little studies have been performed will now 
be discussed. 
 It has been shown that the dielectric properties of tissues in hamster tails changes 
according to variations in blood glucose [33], but this data was only collected at 10 kHz. 
It can be seen (Figure 13) that the permittivity has an inverse relationship with the 
hamster blood glucose level.  
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Another study has shown that red blood cells (erythrocytes) suspended in saline 
have a varying relative permittivity with the biologically active glucose [34]. The 
biologically inactive glucose was not seen to have an effect on the erythrocyte dielectric 
properties, suggesting that the dielectric property changes were a result of a biological 
mechanism rather than the dielectric properties of the glucose itself.  
 Figure 14: Fischer projection of biologically active D-Glucose and the biologically inactive isomer L-Glucose. [34] 
Figure 13: Time varying permittivity (a) and blood glucose concentration (b) of hamster tails, measured invasively. [33] 
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The real relative permittivity of erythrocytes can be seen in Figure 15, for various 
D-glucose concentrations. It can be seen that the permittivity is not monotonic over 
various glucose concentrations.  
 
 
It has been suggested that the intake of glucose in the erythrocytes causes a 
modification of the membrane porosity or activity of membrane ion pumps (Figure 16). 
While this has not been proven, it is reasonable that the permittivity changes are a result 
of a biological interaction with the glucose. This is encouraging, but it does not account 
for any dielectric changes in the blood beyond the erythrocytes. 
There is a clear lack of a model for human blood as a function of glucose level. 
This will be addressed by the present work in a later chapter. 
Figure 15: Permittivity of erythrocytes as a function of frequency and D-glucose concentrations [34] 
21 
 
 
 
1.5 Major Contributions of Present Work 
 
 From this work we define our major contributions as the following: 
1) In vitro testing of blood samples from 20 subjects, in a collaborative study with 
the University at Buffalo, during which the dielectric properties of blood were 
correlated to blood glucose levels (ranging from normal to hyperglycemic). This 
data has been used to modify an existing Cole-Cole model to include a factor that 
describes the dielectric properties of human blood based on blood glucose levels 
as well as frequency. 
2) This model has been used to define the frequency requirements of an impedance 
spectroscopy system. Two antennas (wideband and narrowband) have been 
designed specifically to be sensitive to dielectric changes of blood when placed 
near the human body. A simulation model of layered tissue and blood together 
with an antenna has been created to study the effect of changing glucose levels. 
The antenna’s resonant frequency is shown to increase with an increase in glucose 
Figure 16: Hypothetical model of the effect triggered by increasing glucose concentrations. [34] 
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levels. An analytical model for the narrowband antenna has been developed, 
which has been validated with simulations. 
3) A measurement system has been developed to measure the resonant frequency of 
the antenna. Through the use of a frequency synthesizer, directional coupler, log 
amp and a microprocessor, the board is able to calculate the antenna’s reflection 
coefficient and determine the resonant frequency. An experimental verification 
has been performed, in which an antenna and measurement system were strapped 
(one on each leg) to a patient. The antenna’s resonant frequency was measured by 
a PNA, and the measurement system recorded data as the patient ingested fast 
acting glucose tablets. A comparison of the resonant frequency of the antenna 
measured by the PNA and by the measurement system showed good agreement. It 
is also shown that the antenna’s resonant frequencies increases as the glucose 
level increases, which is consistent with the simulation model.    
1.6 Organization of Present Work 
 
Chapter 1 serves to present the previous work that has been done up to this point, 
in the field of non-invasive blood glucose monitoring and blood dielectric properties, as 
well as presenting the major contributions to the field as provided by this paper. 
Chapter 2 will address the dielectric properties of blood in more detail. 
Specifically, this will involve in vitro measurements of blood samples, from which a 
realistic model will be created that is a function of frequency and blood glucose 
concentrations. This model will be compared to accepted models of previous work. 
Chapter 3 will present a feasibility study for non-invasive blood glucose 
monitoring through simulation. Utilizing the derived model, an antenna will be designed 
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that will be shown to effectively measure changed in blood glucose levels. Simulated 
results will be presented. 
Chapter 4 will present a prototype of a non-invasive blood glucose monitoring 
system. The system will be manufactured and shown to operate as intended, while 
achieving a body-worn form factor. Experimental measurements of the antenna will be 
presented and shown to agree well with the measurement system. 
Chapter 5 will conclude this work by discussing results, reiterating the major 
contributions of the present work, and describing future possible work in the field. 
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2. Dielectric Properties of Blood 
 
2.1 Experimental Blood Measurements 
 
Previous work has shown that there is a relationship between the dielectric 
properties of blood and the glucose concentration. This relationship, while highly 
referenced, has had very little research. One of the major contributions of the present 
work is to provide a model that could be used for future research in this field. 
In an effort to better understand the effect of blood glucose on human blood 
dielectric properties, the Rochester Institute of Technology partnered with the State 
University of New York at Buffalo to perform a study. In this study, 20 subjects 
volunteered (8 diabetics, 12 non-diabetics) to have two samples of their blood drawn. 
Two 3 ml samples were taken, one in a vial containing Ethylenediaminetetraacetic acid 
(EDTA) and one without any additives. EDTA is a chelating agent, which sequesters the 
iron molecules in the blood to prevent clotting [35]. The blood with EDTA was sent to 
the laboratory for glucose concentration testing. The blood without additives was placed 
in a 5 ml dish and the dielectric properties were measured with an Agilent 85070E high 
temperature probe (Figure 17) and an Agilent 8720B Network Analyzer.  
 
 
Figure 17: Agilent 85070E high temperature dielectric probe. [36] 
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2.2 Models for Characterizing Dielectric Properties of Tissue 
 
As mentioned earlier, there already exists an established model for the dielectric 
properties of human blood. It has been generated from the compilation of previous 
studies and experimental measurements (Figure 18) by Gabriel and Gabriel. In the 
present work this is used as a reference to validate our collected data as well as to provide 
a starting point for our model which will be generated.  
 
 
A popular model for dielectrics is a Debye model. It can contain multiple terms, 
which can be used to represent the effect of different types of dispersions (Equation 3). 
This is what allows the model to track the plateau/slope/plateau nature of tissue dielectric 
properties[32]. 
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A modification of the Debye model has been generated to slightly improve its 
usefulness, called a Cole-Cole model (Equation 4). It contains a broadening term α, 
Figure 18: Collected and measured data of permittivity (solid) and conductivity (dashed) of human blood. [31] 
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which can be used to set the frequency range over which each term will dominate the 
equation[32].  
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Ultimately, the researchers found that a fourth order Cole-Cole dispersion model 
provided the best fit to the gathered data for all tissue types. The parameters of this model 
for various tissues are shown in Table 1. 
Tissue Type Blood Fat Muscle Dry Skin Wet Skin 
ε
∞
 4 2.5 4 4 4 
∆ε1 56 3 50 32 39 
∆ε2 5200 15 7000 1100 280 
∆ε3 0 3.3e4 1.2e6 0 3e4 
∆ε4 0 1e7 2.5e7 0 3e4 
τ1 8.377e-12 7.958e-12 7.234e-12 7.234e-12 7.958e-12 
τ2 132.629e-9 15.915e-9 353.678e-9 32.481e-9 79.577e-9 
τ3 - 159.155e-6 318.31e-6 - 1.592e-6 
τ4 - 7.958e-3 2.274e-3 - 1.592e-3 
α1 0.1 0.2 0.1 0 0.1 
α2 0.1 0.1 0.1 0.2 0 
α3 - 0.05 0.1 - 0.16 
α4 - 0.01 0 - 0.2 
σ 0.7 0.01 0.2 0 0 
Table 1: Cole-Cole dispersion parameters for various human tissues [32] 
 
 
2.3 Developing a Glucose-Dependent Model 
 
The discussed model for blood has now been compared to the collected data from 
our study. The average of the collected data is shown in Figure 19 and Figure 20 as a 
function of frequency, with the accepted model for human blood dielectric properties 
[32]. There is agreement between the collected data and the model, but for our purposes 
the model could be adjusted slightly to fit the collected data. 
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Figure 19: Average permittivity of collected data from study and permittivity of established model. 
 
 
Plotted as a function of glucose concentration, all 20 samples are shown in Figure 
21 at 1 GHz and 5 GHz. It can be seen that at concentrations lower that 150 mg/dL, there 
is an inverse relationship between blood glucose concentrations and relative permittivity. 
Figure 20: Average conductivity of collected data from study and conductivity of established model. 
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There does not, however, appear to be a relationship between blood glucose 
concentration and conductivity.  
 
 
From this collected data, the established model can be revised to fit the collected 
data. The result is a Cole-Cole model in the form of (5). 
    	∑ ∆	


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 · 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                	 ∑ ∆	
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where g is blood glucose from 70 to 150 mg/dL, and the model is defined by the 
parameters of Table 2. 
 
Figure 21: Collected data permittivity (left) and conductivity (right) as a function of blood glucose at 1 GHz 
(top) and 5 GHz (bottom). 
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Tissue Type Original Blood Model [32] Modified Blood Model 
ε
∞
 4 2.8 
∆ε1 56 56.5 
∆ε2 5200 5500 
∆ε3 0 0 
∆ε4 0 0 
τ1 8.377e-12 8.377e-12 
τ2 132.629e-9 132.629e-9 
τ3 - - 
τ4 - - 
α1 0.1 0.057 
α2 0.1 0.1 
α3 - - 
α4 - - 
σ 0.7 0.5 
Table 2: Parameters of original and modified blood Cole-Cole models. 
This model can be seen to agree very well with the collected data, shown in 
Figures 22-24.  
Figure 22: Average permittivity of collected data and permittivity of modified model 
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Figure 23: Average conductivity of collected data and conductivity of modified model. 
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Figure 24: Collected permittivity and modified model permittivity for various blood glucose concentrations at 1 
GHz (top) and 5 GHz (bottom). 
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Three samples of collected data from the study are shown in Figure 25 with the 
modified model for the glucose levels measured. 
 
 
While this model agrees well with the collected data, above 150 mg/dL there does 
not appear to be a trend as a function of glucose. It is possible that the mechanism that 
has caused a relationship between glucose concentrations and relative permittivity below 
150 mg/dL is different within a diabetic population. This is supported by the collected 
data; the 12 non-diabetic subjects had glucose concentrations ranging from 72 mg/dL to 
134 mg/dL, while the diabetic subjects had concentrations ranging from 111 mg/dL to 
330 mg/dL. 
Further work is clearly needed to characterize the various impacts of other factors 
(hydration level, glycated hemoglobin, blood pressure, temperature, etc.) and the effects 
on blood dielectric properties, but this is outside the scope of this work. 
 
Figure 25: Three samples from study measuring 72 mg/dL(left), 95 mg/dL (center), and 134 mg/dL (right), with 
modified model. 
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3. Simulations for Non-Invasive Blood Glucose Monitoring 
3.1 Design of an Antenna for Glucose Monitoring 
 
 
Ultimately a non-invasive blood glucose monitoring device is one that could be 
worn around the arm or leg, like the one shown in Figure 26.  
 
  
 
Our proposed method would involve an antenna which would change resonant 
frequency based on the dielectric properties of the tissues present in its fringing fields 
(Figure 27). A similar method has been used previously by this research group to 
effectively characterize tissue dielectric properties [37].  
 
 
 
Figure 26: Conceptual blood glucose measurement form factor. 
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When determining criteria for an antenna, the first factor to consider is the 
frequency range of operation. This can be determined from the already discussed 
dielectric properties of biological tissues. The relative permittivity of blood [32] is shown 
in Figure 28. Below 100 MHz, it can be seen the permittivity rises exponentially. This 
very high permittivity would provide almost complete reflection, making it extremely 
difficult to characterize relatively minor changes in the dielectric properties of various 
tissues. 
 
Figure 27: Detection of tissue properties through antenna fringing field. 
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The penetration depth for blood can be seen in Figure 29. It is the thickness at 
which the radiation within a material falls to approximately 37%. In order for the antenna 
resonant frequency to be affected by the blood dielectric properties, a large penetration 
depth is desirable. It can be seen that at 4 GHz it falls to a minimum desired 1 cm. 
Because of this, the desired frequency range of the antenna is 300 MHz to 4 GHz.  
  
 
Figure 29: Penetration depth of human blood. 
Figure 28: Permittivity of Human Blood. 
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3.2 Human Body Models 
 
In order to design a device that responds accordingly to changes in blood 
dielectric properties, an accurate simulation model must first be created. Initially the 
HFSS human body model was explored (Figure 30), because it has relatively high 
resolution (1mm) details of many tissues. The model, however, does not account for the 
large network of capillary and subcutaneous tissues in any significant detail. The 
“Average” tissue contains large amount of homogeneous tissues, which for our purposes 
need to be separated into skin, blood, fat, and muscle.  
 
 
For this reason, we have adopted the model shown in Figure 31. It is a simplified 
stack of tissue that more accurately represents the tissues present in a human arm or leg. 
It contains 0.015 mm of dry skin, 0.985 mm of wet skin, 0.5 mm of fat, 2.5 mm of blood, 
and 15 mm of muscle. Each of the layers contains the dielectric properties from the 
Figure 30: Ansoft HFSS human body model skeletal (top left), muscular (top right), vascular (bottom left), and 
"average” tissue (bottom right). 
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established database already discussed [32], with the exception of the blood layer, which 
contains the dielectric properties of the new model presented in this work. The antenna 
presented in the next chapter will be designed to be located 1 mm above the dry skin 
layer to prevent the accumulation of perspiration. 
 
 
 
This tissue model will be used for all future simulations in which a human model 
will be discussed.  
3.3 Antenna Design and Simulations 
3.3.1 Design of a Wideband Antenna 
 
 
When initially designing this antenna, it was desired to cover the widest 
frequency range possible while maintaining a planar, easy to manufacture design. 
Because of this, an ultra-wideband monopole antenna has been adopted [38]. The antenna 
Figure 31: Tissue layers used for simplified human body model. 
Antenna 
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has been modified to operate from 1.2 to 6 GHz (Figure 32). In addition to enlarging the 
antenna dimensions, the ground plane needed to be extended to operate at lower 
frequencies. 
 
  
The antenna was modeled in Ansoft HFSS from 300 MHz to 6 GHz, the return 
loss is shown in Figure 33 in free space and with the tissue model (Figure 31) present. It 
is clear that the resonant frequencies of the antenna have shifted significantly. 
Figure 32: Modified UWB antenna with dimensions in mm. 
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A simulation has been performed using the model for the three different blood 
glucose concentrations plotted in Figure 25. The resonance that in free space resonated at 
2.33 GHz (ωr in Figure 31) was found to shift to 2.209 GHz, 2.213 GHz, and 2.219 GHz 
for 72 mg/dL, 95 mg/dL, and 134 mg/dL, respectively (Figure 34). 
 
Figure 33: Modified UWB antenna return loss. 
ωr 
ωr 
Figure 34: Modified UWB antenna return loss for varying glucose concentrations. 
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These results, while encouraging, were difficult to analyze due to the broad 
response of the UWB antenna. Work has been done to determine the equivalent model of 
an UWB antenna [39], but performing similar analysis on the collected and simulated 
data was not found to be beneficial. 
3.3.2 Design of a Narrowband Antenna 
 
 
The antenna has been modified further by removing the “steps” in the design 
which provided an ultra-wideband response. The new antenna (Figure 35) is now a 
narrowband (NB) resonant antenna with a free space resonant frequency of 1.85 GHz. 
 
 
The antenna was modeled in Ansoft HFSS from 300 MHz to 4 GHz; the return 
loss is shown in Figure 36 in free space and with the tissue model (Figure 31) present. 
This antenna is also shown to shift resonant frequencies significantly. 
Figure 35: Modified NB antenna with dimensions in mm. 
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A simulation with the NB antenna has been performed for the three different 
blood glucose concentrations plotted in Figure 23. The resonance that in free space 
resonated at 1.85 GHz (ωr in Figure 36) was found to shift to 1.301 GHz, 1.303 GHz, and 
1.307 GHz for 72 mg/dL, 95 mg/dL, and 134 mg/dL, respectively (Figure 37). 
 
 
Figure 36: Simulated NB antenna return loss. 
ωr 
ωr 
ωr 
Figure 37: NB antenna return loss for varying glucose concentrations. 
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3.3.3 Analytical Model of Narrowband Antenna 
 
 
A method to determine a lumped element equivalent circuit has been successful 
for dipole antennas [40]. This method has been applied to this planar antenna, with some 
minor additions (Figure 38). The feed network can be modeled as a transmission line 
between the radiator and the port. Figure 38 shows the real and imaginary impedance of 
the simulated antenna and the equivalent circuit model. Good agreement can be seen 
between the model and the simulated data. The values of this model that match the free 
space resonance at 1.8 GHz can be found in Table 3. 
 
Figure 38: Lumped element model of NB antenna. 
Es1 Ls1 (nH) Cs1 (pF) Rs1 (Ω) Lp1 (nH) Rp1 (Ω) Cp1 (pF) 
50 ohm transmission line. 
230 degree Delay at 1.8 GHz. 
1.5 2.55 29 1.32 36.5 3.5 
Table 3: Lumped element values of analytical model. 
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The presence of tissue near the antenna will act as an additional capacitor Cp2 
present in the parallel resonant RLC network that is a function of the tissue dielectric 
properties and position (Figure 40). 
 
Figure 40: Analytical model accounting for tissue layers. 
To verify the validity of this model, the antenna has been simulated in HFSS with 
a dielectric block at varying distances from the antenna’s radiator (Figure 41). The 
dielectric has been simulated for a permittivity ranging from 1 to 7, and for distances 
between 1 mm and 7 mm. The Cp2 capacitor values have then been determined in the 
equivalent circuit to match the antenna reactance from the HFSS simulations. The various 
Figure 39: HFSS simulation and analytical model. 
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Cp2 values determined are plotted in Figure 42 as a function of the dielectric permittivity 
and distance from the antenna. 
 
Figure 41: Antenna orientation used to validate model. 
 
 
 
It can be seen that for all distances, the changes in Cp2 are nearly a linear function 
of permittivity, which would be expected for a capacitor. This confirms the validity of 
this model. 
While this shows how the antenna’s resonant frequency has the ability to 
characterize the dielectric properties of tissues, it also emphasizes the effect of 
Figure 42: Capacitance of Cp2 for varying dielectrics. 
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positioning on the antenna response. If a consistent position is not maintained with the 
antenna, the proximity of the antenna to human tissues could provide unwanted variation. 
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4. Prototype Non-Invasive Wireless Blood Glucose Monitor 
4.1 Antenna Performance 
 
The modified UWB antenna was manufactured as specified on FR4 dielectric, 
shown in Figure 43. The performance of this antenna was verified outside of the 
measurement system. 
  
 
The return loss of the manufactured antenna in free space compared to the 
simulated antenna is shown in Figure 44. There is good agreement between the 
simulation and the manufactured antenna.  
Figure 43: Manufactured UWB antenna on FR4. 
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An experiment was performed in which the resonant frequency of the antenna was 
measured while pressed against a subject’s lower leg. After 6 minutes, 16g of fast-acting 
glucose was ingested. The resonant frequency can be seen plotted in Figure 45 with the 
blood glucose level measured with a ONETOUCH UltraMini. After glucose ingestion, 
there is a shift in both the resonant frequency of the antenna as well as blood glucose 
level.  
Figure 44: Simulated and measured response of UWB antenna. 
ωr 
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The results from this experiment are very promising. Similar data will be 
measured on the NB antenna as a part of a complete measurement system, described in 
more detail in the next section. 
4.2 Measurement System Design Details 
 
In order to accurately measure the resonant frequency of the planar antenna, a 
system was devised in which the phase component of the antenna could be measured as 
well. The implemented system block diagram can be seen in Figure 46. A microcontroller 
configures a frequency synthesizer to a particular frequency; the signal is filtered, 
amplified and terminated into the antenna. A directional coupler produces the forward 
and reflected signals that are sent to log amps.  
Figure 45: UWB response recorded over time. 
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Figure 46: Block diagram of measurement system. 
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The particular log amp that is used is an Analog Devices AD8302, which provides 
amplitude and phase comparison output of the two input signals (Figure 47). In the 
configuration implemented in this design, the output of the AD8302 is the reflection 
coefficient of the antenna in dB and degrees phase. Unfortunately it only provides a 
measurement of the phase difference magnitude, so there is no indication of the phase 
sign. This was not found to be an issue, since a significant reactance was found to be 
present at resonance. 
 
 
 
The frequency synthesis was achieved through the use of the Analog Devices part 
ADF4350 (Figure 48). It contains an internal VCO with frequency dividers, as well as an 
on-board phase-locked loop, allowing a single part to generate signals from 125 MHz to 
4.4 GHz. Due to the harmonics from the frequency division, however, low-pass filters are 
required to filter harmonics. 
Figure 47: AD8302 block diagram [41] 
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The directional coupler used was a Minicircuits SYBD-19-172. It has been chosen 
due to its high directivity and wide frequency range. The maximum dynamic range of the 
AD8302 is 30 dB, so directivity as close to 30 dB was desired. 
The board was designed and routed in Cadsoft Eagle software. The complete 
schematic, bill of materials, layout drawings, and errata can be found in the appendices. 
The completed and populated board (Figure 49) shows how the board was designed to 
contain components only on the side away from the subject. 
 
Figure 48: ADF4350 block diagram [42] 
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4.3 Evaluation of System Operation and Performance 
 
Prior to controlling the board with the ADF4350, a signal generator was 
connected to the board and swept from 200 MHz to 2.5 GHz. The return loss magnitude 
and phase voltages that were output from the AD8302 were measured with an 
oscilloscope (Figure 50). It can be seen that the 1.85 GHz resonance is present due to the 
antenna. 
Figure 49: Measurement system with included antenna. 
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The same data was recorded with an arm pressed gently against the antenna. It 
can be seen (Figure 51) that the resonance has shifted to approximately 900 MHz.  
  Figure 51: Output voltages of AD8302 with arm present. 
Resonance shift to 
900 MHz 
Figure 50: Output voltages of AD8302. 
Reflection coefficient 
magnitude at 1.8 GHz 
Reflection coefficient phase 
at 1.8 GHz 
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With the ADF4350 and microcontroller controlling the board, and a computer 
collecting data through the serial port, similar data can be seen with and without an arm 
present (Figure 52). 
 
  
 
The resonant shift from 1.8 GHz to 0.9 GHz shows that the antenna is working as 
intended. Figure 53 shows the collected board data plotted with the antenna measured 
directly by a network analyzer. Some of the discrepancies could be due to higher 
harmonic content on the measurement board, differences in the antenna matching as a 
result of the directional coupler, or isolation issues on the board. The positive return 
losses indicate that at some frequencies the reflected signal from the coupler is higher 
than the forward signal. While these effects are unwanted, it is also apparent that the 
measurement system is operating more-or-less as intended. 
Figure 52: Return loss of complete measurement system. 
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The microcontroller has been configured to sweep only from 700 MHz to 1.1 
GHz and to decrease the frequency step when a resonance is detected (by lower return 
loss). When the antenna is pressed against an arm, a clear resonant can be seen and 
identified by rapid change in phase (Figure 54). This data has been gathered and captured 
by a LabView program (Figure 55). This change in phase at the resonance is used to 
detect changes in the antenna resonant frequency.  
 
Figure 53: Return loss of system compared to antenna alone. 
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Figure 55: LabView program used to analyze data. 
Figure 54: Return loss and phase of complete measurement system. 
ωr 
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Figure 56: Verification of measurement system response with blood glucose. 
4.4 Measurement System Results 
 
The final verification of the complete system operation was performed by the 
following experiment. The antenna from an unpopulated measurement board was 
connected to a network analyzer with a cable. The antenna was gently held on a subject’s 
left leg with an Ace bandage. A populated measurement board was held on the subject’s 
right leg in the same fashion. 20 g of fast-acting glucose was ingested at the start of the 
test. The antenna response and the subject’s blood glucose were manually measured 
(using a Network Analyzer and a ONETOUCH UltraMini) repeatedly. The measurement 
board was measured through the LabView program. The change in the response of the 
antennas along with the blood glucose levels can be seen in Figure 56. 
 
 It should be noted that the absolute resonant frequencies of the measurement 
board and the antenna were not equal. It is believed that this was a result of slightly 
different placements of the two boards, as well as differences in the antenna match. The 
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SMA connector on the unpopulated board was not mounted in an ideal manner, providing 
a less-than-optimal match between the cable and antenna. Regardless, this test verifies 
proper operation of the measurement system. 
When Figure 56 is analyzed, the relationship between blood glucose levels and 
resonant frequency can be determined to be approximately 9E-06 (mg/dL)/Hz. This slope 
can be used to predict the blood glucose levels for other experiments.  
 
 
A test similar to the one shown in Figure 45 was performed with the complete 
measurement system. The results of the experiment are shown in Figure 57. As expected 
the resonant frequency of the antenna increases with blood glucose levels. If a one-point 
calibration is performed (to account for the differences in starting frequencies due to 
antenna positioning) using the 9E-06 (mg/dL)/Hz relationship, the data for the 
measurement system can be seen to predict glucose levels reasonably well. If plotted on a 
Figure 57: Measurement system response and blood glucose over time. 
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Clark error grid (Figure 58), all of the data points are found to occur within the desired 
zone A [43]. 
 
 
 
Clearly this data is not definitive as the blood glucose range is limited, but it does 
show promise for this type of a system to be developed. Further work is needed to test the 
measurement system at a wider range of blood glucose levels. 
  
Figure 58: Clarke error grid for measurement system. 
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5. Conclusions and Future Work 
 
In conclusion, the present work has made the following contributions to the 
research of non-invasive blood glucose monitoring. A study was performed, during 
which the in vitro testing of blood samples has been able to correlate the dielectric 
properties of blood to blood glucose levels. This data has been used to modify the Cole-
Cole model which describes the dielectric properties of blood based on blood glucose 
levels and frequency. 
The model has been used to determine the frequency range best suited for an 
impedance spectroscopy system. Two antennas have been designed in this frequency 
range to be sensitive to dielectric changes in blood when placed next to the human body. 
These antennas, along with a simulation model of layered tissue and blood, has been 
created to study the effects of various blood glucose levels. In simulations, the antennas’ 
resonant frequency has been shown to increase with blood glucose levels. 
These simulated results have been supported by experimental evidence. An 
antenna, measured by a PNA, has been strapped to the leg of a patient. After ingesting 
fast-acting glucose tablets, the resonant frequency of the antenna increases with the 
patient’s blood glucose level. An embedded measurement system, designed in this work, 
was simultaneously strapped to the patient’s other leg. The resonant frequency of the 
antenna in the measurement system was also seen to increase with blood glucose level. 
The measurement system and the antenna both have shown promising results that agree 
with the simulations.    
5.1 Future Work 
 
Future work in this field can be defined as the following: 
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1. Further in-vitro clinical studies need to be done on diabetic patients with different 
blood glucose levels, using an antenna and measuring the shift in its resonant 
frequency. This data can be used to develop the relationship between dielectric 
properties of blood, glucose levels, and the antenna response. 
2. An accurate analytical model to measure blood glucose levels through dielectric 
properties needs to be developed. There are many factors involved in this 
measurement and understanding them is critical to creating a model. 
3. With multiple receive antennas, diversity techniques could be developed to 
improve the accuracy of the estimation of the glucose levels. 
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Appendix A: Measurement System Schematic 
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Appendix B: Measurement System Bill of Materials 
 
Part Value Device Package Type 
C1 0.1uF C-USC0603 C0603 Capacitor 
C2 0.1uF C-USC0603 C0603 Capacitor 
C3 22pF C-USC0603 C0603 Capacitor 
C4 0.1uF C-USC0603 C0603 Capacitor 
C5 0.1uF C-USC0603 C0603 Capacitor 
C6 0.1uF C-USC0603 C0603 Capacitor 
C7 0.1uF C-USC0603 C0603 Capacitor 
C8 0.1uF C-USC0603 C0603 Capacitor 
C9 0.1uF C-USC0603 C0603 Capacitor 
C10 0.1uF C-USC0603 C0603 Capacitor 
C11 0.1uF C-USC0603 C0603 Capacitor 
C12 0.1uF C-USC0603 C0603 Capacitor 
C13 0.1uF C-USC0603 C0603 Capacitor 
C14 0.1uF C-USC0603 C0603 Capacitor 
C15 0.1uF C-USC0603 C0603 Capacitor 
C16 0.1uF C-USC0603 C0603 Capacitor 
C17 0.1uF C-USC0603 C0603 Capacitor 
C18 1nF C-USC0603 C0603 Capacitor 
C19 1nF C-USC0603 C0603 Capacitor 
C20 1nF C-USC0603 C0603 Capacitor 
C21 150pF C-USC0603 C0603 Capacitor 
C22 2.7nF C-USC0603 C0603 Capacitor 
C23 180pF C-USC0603 C0603 Capacitor 
C24 180pF C-USC0603 C0603 Capacitor 
C25 1nF C-USC0603 C0603 Capacitor 
C26 0.1uF C-USC0603 C0603 Capacitor 
C27 10pF C-USC0603 C0603 Capacitor 
C28 10pF C-USC0603 C0603 Capacitor 
C29 0.1uF C-USC0603 C0603 Capacitor 
C30 0.1uF C-USC0603 C0603 Capacitor 
C31 10pF C-USC0603 C0603 Capacitor 
C32 1nF C-USC0603 C0603 Capacitor 
C33 1nF C-USC0603 C0603 Capacitor 
C34 1nF C-USC0603 C0603 Capacitor 
C35 1nF C-USC0603 C0603 Capacitor 
C36 100pF C-USC0603 C0603 Capacitor 
C37 0.1uF C-USC0603 C0603 Capacitor 
C38 1nF C-USC0603 C0603 Capacitor 
C39 1nF C-USC0603 C0603 Capacitor 
C40 0.1uF C-USC0805 C0805 Capacitor 
C41 0.1uF C-USC0805 C0805 Capacitor 
C42 0.1uF C-USC0805 C0805 Capacitor 
C43 0.1uF C-USC0805 C0805 Capacitor 
C44 0.1uF C-USC0805 C0805 Capacitor 
C45 0.1uF C-USC0805 C0805 Capacitor 
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C46 0.1uF C-USC0805 C0805 Capacitor 
C47 0.1uF C-USC0805 C0805 Capacitor 
C48 15pF C-USC0805 C0805 Capacitor 
C49 15pF C-USC0805 C0805 Capacitor 
C50 10uF CPOL-USCT3216 CT3216 Capacitor 
C51 0.1uF C-USC0805 C0805 Capacitor 
C52 0.1uF C-USC0805 C0805 Capacitor 
FILTER-1 800 MHz LFCN-800 FV1206 Filter 
FILTER-2 1200 MHz LFCN-1200 FV1206 Filter 
FILTER-3 1700 MHz LFCN1700 FV1206 Filter 
FILTER-4 2400 MHz LFCN-2400 FV1206 Filter 
IC1 SGA-2163 SGA-2163 SOT363_INFINEON LNA 
IC2 SKY13322 SKY13322 SKY13322 Switch 
IC3 SKY13322 SKY13322 SKY13322 Switch 
IC4 PIC18F2580 PIC18F2580_28W SO28W Microcontroller 
IC5 SKY12329-350LF SKY12329-350LF QFN3X3 Attenuator 
IC6 MAX3232CWE MAX3232CWE SO16L RS232 Convertor 
IC7 LM2937ET-3.3 78XXL 78XXL Linear Regulator 
J2 TC2030-MCP TC2030-MCP TC2030-MCP Microchip Connector 
R1 71 R-US_R0603 R0603 Resistor 
R2 96 R-US_R0603 R0603 Resistor 
R3 DNI R-US_R0603 R0603 Resistor 
R4 96 R-US_R0603 R0603 Resistor 
R5 0 R-US_R0603 R0603 Resistor 
R6 DNI R-US_R0603 R0603 Resistor 
R7 20 nH 0603CS R0603 Inductor 
R8 20 R-US_R0603 R0603 Resistor 
R9 DNI R-US_R0603 R0603 Resistor 
R10 DNI R-US_R0603 R0603 Resistor 
R11 0 R-US_R0603 R0603 Resistor 
R12 0 R-US_R0603 R0603 Resistor 
R13 0 R-US_R0603 R0603 Resistor 
R14 13000 R-US_R0603 R0603 Resistor 
R15 1500 R-US_R0603 R0603 Resistor 
R16 1500 R-US_R0603 R0603 Resistor 
R17 0 R-US_R0603 R0603 Resistor 
R18 3.9nH 0603CS R0603 Inductor 
R19 3.9nH 0603CS R0603 Inductor 
R20 0 R-US_R0603 R0603 Resistor 
R21 5100 R-US_R0603 R0603 Resistor 
R22 1000 R-US_R0603 R0603 Resistor 
R23 0 R-US_R0603 R0603 Resistor 
R24 DNI R-US_R0603 R0603 Resistor 
R25 0 R-US_R0603 R0603 Resistor 
R26 50 R-US_R0603 R0603 Resistor 
R27 50 R-US_R0603 R0603 Resistor 
R28 0 R-US_R0603 R0603 Resistor 
R29 10000 R-US_R0603 R0603 Resistor 
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R30 0 R-US_R0603 R0603 Resistor 
T1 SYBD_COUPLER SYBD-19-172 SYBD Directional Coupler 
U$1 AD8302 AD8302 TSSOP14 Dual Log Amp 
U$3 ADF4350 ADF4350 LFCSP32 Frequency Synthesizer 
X1 D-SUB9-H5M09RA D-SUB9-H5M09RA H5M09RA Connector 
X2 10 MHz CRYSTALHC49UP HC49UP Crystal 
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Appendix C: Measurement System Board Layout 
 
Layer 1: 
 
 
Layer 2: 
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Layer3: 
 
 
Layer4: 
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Appendix D: Measurement System Board Errata 
 
The latch enable line was not originally connected on the board layout. To fix this, a 
jumper wire must be run from pin 5 of IC4 (microcontroller) to pin 3 of U$3. 
 
The microcontroller ground pin8 has accidentally been wired to 3.3V in the layout. To fix 
this, the 3.3V trace to pin 8 of IC4 must be cut, and pin 8 must be connected with a 
jumper wire to pin 19 of IC4. 
